Results 171 to 180 of about 62,115 (257)

Noncoding RNA TY1 reverses fibrosis in systemic sclerosis by attenuating the cGAS/STING pathway. [PDF]

JCI Insight
Jones XM, Soussi S, Ciullo A, Tsi K, Liu W, Li L, Fournier M, Mesquita T, Marchevsky AM, Bottini N, Boin F, Ibrahim AG, Marbán E.   +12 more
europepmc   +1 more source

Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience. [PDF]

CVIR Endovasc
Ubaldi N, Khattar AS, Storey M, Adu J, Mailli L, Morgan R, Muir T, Ratnam L.   +7 more
europepmc   +1 more source

Gut microbiota dynamics and metabolic pathways associated with bleomycin-induced pulmonary fibrosis progression. [PDF]

PeerJ
Cong J, Xu W, Zhang Y, Ding X, Cui S, Chi X, Yang X.   +6 more
europepmc   +1 more source

Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis. [PDF]

Animal Model Exp Med
Yegen CH, Maakoul Z, Marchant D, Callard P, Bourse J, Bernaudin JF, Nunes H, Planès C, Boncoeur E, Voituron N.   +9 more
europepmc   +1 more source

Early Fibrotic Remodeling Remains Responsive to Autologous Fat Grafting: Histological Findings in a Rat Model. [PDF]

In Vivo
Bogdan RG, Blidisel A, Cimpean AM, Ciobota I, Helgiu A, Nicolau M, Bodea IC, Heredea RE, Crainiceanu ZP.   +8 more
europepmc   +1 more source

Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data. [PDF]

J Korean Med Sci
Byeon S, Kang KW, Kwak K, Yoo KH, Yoon SE, Kim WS, Kim SJ.   +6 more
europepmc   +1 more source

Fuelling repair: metabolic regulation of alveolar type 2 cell fate in lung regeneration and disease. [PDF]

Dis Model Mech
Wugk S, Kenny S, Masood F, Htoo ET, Cloonan SM.   +4 more
europepmc   +1 more source

Managing malignant recurrent pericardial effusion in a palliative patient with bleomycin sclerotherapy: A case report from Bangladesh. [PDF]

Medicine (Baltimore)
Das S, Bhuiyan AKMMR, Alam A, Singha CK, Chowdhury MK.   +4 more
europepmc   +1 more source

Safety evaluation of bleomycin in ovarian cancer treatment: A pharmacovigilance analysis using Food and Drug Administration adverse event reporting system data. [PDF]

J Int Med Res
Zhou X, Wang X, Su L, Hao Y.
europepmc   +1 more source